P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL

Detalles Bibliográficos
Autores principales: Zhang, L., Liu, X., Wang, X., Chang, Y., Fu, X., Li, X., Li, L., Zhang, X., Yan, J., Nan, F., Zhu, L., Sun, Z., Yu, H., Guo, S., Sang, W., Wang, L., Zhang, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431228/
http://dx.doi.org/10.1097/01.HS9.0000847824.69595.f0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431228/
http://dx.doi.org/10.1097/01.HS9.0000847824.69595.f0

Ejemplares similares